Wendy Ansell
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery.
Journal: European urology focus
Published: November 24, 2019
Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy.
Journal: BJU international
Published: November 06, 2019
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG).
Journal: British journal of cancer
Published: October 13, 2019
Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?
Journal: BJU international
Published: October 17, 2017
A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer.
Journal: Urologia internationalis
Published: January 11, 2017
Bone metastases in germ cell tumours: lessons learnt from a large retrospective study.
Journal: BJU international
Published: June 26, 2013
The efficacy of tacrolimus and sirolimus in heavily pre-treated unresectable thymic malignancies.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 15, 2012
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 05, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026